To the full analysis
Buyback calculator for Abivax
Abivax stock: key metrics
ABVX.PAAbivax had an operating margin of 0% and a return on invested capital (ROIC) of −58.5% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2013 | −115.0% | −9,879.8% | −7,871.5% |
| 2014 | −326.8% | −7,528.2% | −7,567.0% |
| 2015 | −6,370.2% | −8,006.6% | −6,997.8% |
| 2016 | −9,598.7% | −12,076.8% | −9,475.5% |
| 2017 | −2,841.6% | −3,974.7% | −3,152.2% |
| 2018 | −1,786.6% | −2,344.7% | −1,941.5% |
| 2019 | no data | no data | no data |
| 2020 | −371.4% | −282,821.4% | −268,221.4% |
| 2021 | −321.6% | −141,045.9% | −114,735.1% |
| 2022 | 98.5% | −1,414.7% | −1,325.3% |
| 2023 | 97.2% | −2,756.5% | −3,197.1% |
| 2024 | 89.8% | −1,718.2% | −1,633.1% |
| 2025 | no data | no data | no data |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2013 | −17.3% | −17.7% | −15.3% |
| 2014 | −15.0% | −12.1% | −13.4% |
| 2015 | −22.2% | −43.6% | −20.9% |
| 2016 | −25.2% | −42.9% | −23.6% |
| 2017 | −23.3% | −34.3% | −20.9% |
| 2018 | −45.7% | −47.4% | −29.3% |
| 2019 | −100.0% | −95.1% | −59.2% |
| 2020 | −100.0% | −68.6% | −52.7% |
| 2021 | −100.0% | −58.6% | −38.5% |
| 2022 | −100.0% | −73.0% | −82.8% |
| 2023 | −75.4% | −63.2% | −45.2% |
| 2024 | −100.0% | −69.3% | −85.9% |
| 2025 | −73.8% | −58.5% | −57.5% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Jan 2019)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.